Hypoxia, or low oxygen levels, is common in many tumors due to inadequate blood supply. Hypoxic conditions can lead to the activation of hypoxia-inducible factors (HIFs), which promote angiogenesis, survival, and metastasis of cancer cells. Hypoxia also contributes to resistance to chemotherapy and radiation therapy, making it a critical factor in cancer progression.
